Breast Clinic, Department of Medical Oncology, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Case Report
Breast Cancer Relapse in a BRCA2-Mutated Patient with Moyamoya Disease Treated with Mastectomy under Hypnosis Sedation : a Case Report
Author(s): Louis Van Hees, Pauline Georges, Gabriela Gujda, Marie-Agnes Docquier, Christine Watremez, François Mestdagh , Zineb Hafdallah, Andre Peeters, Jennifer Hammer, Latifa Fellah, Francois P Duhoux and Martine Berliere*
Moyamoya Disease (MMD) and breast cancer due to a BRCA2 germline mutation are both rare diseases, and there are no data in the literature to assess the cumulative incidence of these two complex conditions. We present here the case of a 62-year-old woman with a history of MMD who developed a recurrence of invasive non-special type breast carcinoma in the right breast. The patient was diagnosed with a BRCA2 germline mutation in 2018 and an MMD in 2023. The cancer extension assessment was negative. The patient refused a surgical procedure under general anesthesia out of fear of complications. She therefore underwent a simple right mastectomy under hypno-sedation with an excellent postoperative evolution. Given the tumor’s prognostic factors, she was treated with an aromatase inhibitor and is currently in complete remission... View More»
DOI:
10.35248/2332-2594.24.10(4).001-004